Gilead HPI licensing adds $35M now + $330M milestones; Phase 2 starts by 2026; strong cash runway. Click for this ASMB update ...
Opinion
Regtechtimes on MSNOpinion
Auditable AI at scale: Designing experimentation pipelines that prove lift without compromising integrity
AI systems are no longer making reversible decisions. They now influence pricing, approve transactions, shape visibility, and determine which messages reach millions of users. In this environment, a ...
(CSE: NIOB) (FSE: KS82.F) (OTCQB: NIOMF) has spent the first quarter of 2026 identifying multiple priority drill targets ...
Good day, and welcome to the One Stop Systems, Inc. Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded. As part of the discussion today, ...
Multiply, the AI-native media agency for B2B companies. has emerged from stealth with $9.5 million (€8.2m) in funding to ...
Multiply is the first hybrid AI + human media agency for B2B companies. Launches Self-Learning Advertising, where ads learn from company data and continuously improve.
Morning Overview on MSN
New tool automates key steps in genome sequencing analysis
A Snakemake-based pipeline called Pipeasm automates key steps of genome assembly, from raw read trimming through scaffolding and contamination screening, and the authors report up to 99.6% BUSCO ...
In a single experiment, scientists can decipher the entire genomes of many patient samples, animal models, or cultured cells.
How LinkedIn replaced five feed retrieval systems with one LLM model — and what engineers building recommendation pipelines can learn from the redesign.
Defence AI teams are turning to synthetic data because real operational data can be scarce, sensitive, or hard to move. But synthetic data only helps if you can show it represents the real conditions ...
Integrating AI into chip workflows is pushing companies to overhaul their data management strategies, shifting from passive storage to active, structured, and machine-readable systems. As training and ...
ELRIG, a not-for-profit, volunteer-led organization dedicated to the global drug discovery community, today announced the keynote speakers for Advances in Cell-based Screening 2026, taking place at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results